Merck & Co., Inc. - MRK

MRK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
MRK	1.2	-1.0	-0.0	-12.6	-20.7	-3.1	38.9	22.2	76.3	25660.7
S&P 500	0.0	0.8	5.6	9.4	14.5	32.4	33.3	95.6	191.7	34157.5

Compare MRK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	MRK
name	Merck & Co., Inc.
price	101.85
changes percentage	1.23
change	1.24
day low	100.62
day high	102.45
year high	134.63
year low	94.48
market cap	257643834000
price avg 50	105.48
price avg 200	119.73
exchange	NYSE
volume	8081616
avg volume	10572595
open	100.75
previous close	100.61
eps	4.78
pe	21.31
earnings announcement	2025-02-04T05:00:00.000+0000
shares outstanding	2529640000
timestamp	2024-12-03 21:00:58

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 29.0%

Overall Quarterly Financial Health: 53.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000310158
revenue	60115000000	59283000000	1.40
gross profit	43989000000	41872000000	5.06
gross profit ratio	0.73	0.71	3.60
research and development expenses	30531000000	13548000000	125.35
operating expenses	40912000000	23590000000	73.43
interest income	365000000	157000000	132.48
interest expense	1146000000	962000000	19.13
ebitda	6907000000	21315000000	-67.60
ebitdaratio	0.11	0.39	-70.78
operating income	2954000000	19399000000	-84.77
operating income ratio	0.05	0.33	-84.98
net income	365000000	14519000000	-97.49
net income ratio	0.01	0.24	-97.52
eps	0.14	5.73	-97.56

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 60,115 million in 2023 from 59,283 million in 2022 representing a change of 1.4%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 43,989 million in 2023 from 41,872 million in 2022 representing a change of 5.06%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 30,531 million in 2023 from 13,548 million in 2022 representing a change of 125.35%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 6,907 million in 2023 from 21,315 million in 2022 representing a change of -67.6%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 2,954 million in 2023 from 19,399 million in 2022 representing a change of -84.77%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 365 million in 2023 from 14,519 million in 2022 representing a change of -97.49%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 40,912 million in 2023 from 23,590 million in 2022 representing a change of 73.43%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Earnings per Share (EPS): EPS increased to 0.14 in 2023 from 0.14 in 2022 representing a change of -97.56%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000310158
revenue	16657000000	16156000000	3.10
gross profit	12577000000	11863000000	6.02
gross profit ratio	0.76	0.73	2.83
research and development expenses	5862000000	2886000000	103.12
operating expenses	8495000000	5594000000	51.86
interest income	127000000	69000000	84.06
interest expense	330000000	310000000	6.45
ebitda	5606000000	7380000000	-24.04
ebitdaratio	0.34	0.45	-25.85
operating income	3984000000	6269000000	-36.45
operating income ratio	0.24	0.39	-38.36
net income	3157000000	5455000000	-42.13
net income ratio	0.19	0.34	-43.87
eps	1.25	2.15	-41.86

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 16,657 million in 2024Q3 from 16,156 million in 2024Q2 representing a change of 3.1%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 12,577 million in 2024Q3 from 11,863 million in 2024Q2 representing a change of 6.02%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 5,862 million in 2024Q3 from 2,886 million in 2024Q2 representing a change of 103.12%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 8,495 million in 2024Q3 from 5,594 million in 2024Q2 representing a change of 51.86%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 5,606 million in 2024Q3 from 7,380 million in 2024Q2 representing a change of -24.04%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 3,984 million in 2024Q3 from 6,269 million in 2024Q2 representing a change of -36.45%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 3,157 million in 2024Q3 from 5,455 million in 2024Q2 representing a change of -42.13%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.25 in 2024Q3 from 1.25 in 2024Q2 representing a change of -41.86%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000310158
total assets	106675000000	109160000000	-2.28
total liabilities	69040000000	63102000000	9.41
total equity	37635000000	46058000000	-18.29
cash and cash equivalents	6841000000	12694000000	-46.11
short term investments	252000000	498000000	-49.40
long term investments	252000000	1015000000	-75.17
total current assets	32168000000	35722000000	-9.95
total non current assets	74507000000	73438000000	1.46
total current liabilities	25694000000	24239000000	6.00
total non current liabilities	43346000000	38863000000	11.54
common stock	1788000000	1788000000	0.00
retained earnings	53895000000	61081000000	-11.76
total debt	36268000000	30691000000	18.17

Overall Score of Annual Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 106,675 million in 2023 from 109,160 million in 2022 representing a change of -2.28%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 69,040 million in 2023 from 63,102 million in 2022 representing a change of 9.41%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 37,635 million in 2023 from 46,058 million in 2022 representing a change of -18.29%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 6,841 million in 2023 from 12,694 million in 2022 representing a change of -46.11%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 252 million in 2023 from 498 million in 2022 representing a change of -49.4%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 32,168 million in 2023 from 35,722 million in 2022 representing a change of -9.95%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 25,694 million in 2023 from 24,239 million in 2022 representing a change of 6.0%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 53,895 million in 2023 from 61,081 million in 2022 representing a change of -11.76%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 36,268 million in 2023 from 30,691 million in 2022 representing a change of 18.17%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000310158
total assets	117532000000	112630000000	4.35
total liabilities	72972000000	68982000000	5.78
total equity	44560000000	43648000000	2.09
cash and cash equivalents	14593000000	11346000000	28.62
short term investments	0	50000000	-100.00
long term investments	575000000	1649000000	-65.13
total current assets	40361000000	38205000000	5.64
total non current assets	63592000000	74425000000	-14.56
total current liabilities	29586000000	26060000000	13.53
total non current liabilities	34982000000	42922000000	-18.50
common stock	1788000000	1788000000	0.00
retained earnings	61384000000	60187000000	1.99
total debt	38131000000	37788000000	0.91

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 117,532 million in 2024Q3 from 112,630 million in 2024Q2 representing a change of 4.35%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 44,560 million in 2024Q3 from 43,648 million in 2024Q2 representing a change of 2.09%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 14,593 million in 2024Q3 from 11,346 million in 2024Q2 representing a change of 28.62%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 40,361 million in 2024Q3 from 38,205 million in 2024Q2 representing a change of 5.64%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 61,384 million in 2024Q3 from 60,187 million in 2024Q2 representing a change of 1.99%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 72,972 million in 2024Q3 from 68,982 million in 2024Q2 representing a change of 5.78%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024Q3 from 50 million in 2024Q2 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 29,586 million in 2024Q3 from 26,060 million in 2024Q2 representing a change of 13.53%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 38,131 million in 2024Q3 from 37,788 million in 2024Q2 representing a change of 0.91%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000310158
net change in cash	-5864000000	4606000000	-227.31
operating cash flow	13006000000	19095000000	-31.89
free cash flow	9143000000	14707000000	-37.83
capital expenditure	-3863000000	-4388000000	11.96
depreciation and amortization	3872000000	3909000000	-0.95
deferred income tax	-1899000000	-1568000000	-21.11
stock based compensation	645000000	541000000	19.22
accounts payables	-380000000	-289000000	-31.49
inventory	-816000000	-161000000	-406.83
acquisitions net	-12032000000	-121000000	-9,843.80
investments in property plant and equipment	-3863000000	-4388000000	11.96
net cash used for investing activites	-14083000000	-4960000000	-183.93
debt repayment	4184000000	-2251000000	285.87
common stock issued	0	384000000	-100.00
common stock repurchased	-1346000000	-384000000	-250.52
dividends paid	-7445000000	-7012000000	-6.18
net cash used provided by financing activities	-4810000000	-9119000000	47.25
cash at end of period	6909000000	12773000000	-45.91
accounts receivables	-1148000000	-644000000	-78.26
cash at beginning of period	12773000000	8167000000	56.40

Overall Score of Annual Cashflow Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -5,864 million in 2023 from 4,606 million in 2022 representing a change of -227.31%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 13,006 million in 2023 from 19,095 million in 2022 representing a change of -31.89%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 9,143 million in 2023 from 14,707 million in 2022 representing a change of -37.83%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -3,863 million in 2023 from -4,388 million in 2022 representing a change of 11.96%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 645 million in 2023 from 541 million in 2022 representing a change of 19.22%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 380 million in 2023 from 289 million in 2022 representing a change of -31.49%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -7,445 million in 2023 from -7,012 million in 2022 representing a change of -6.18%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Accounts Receivables: Accounts Receivables decreased to -1,148 million in 2023 from -644 million in 2022 representing a change of -78.26%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000310158
operating cash flow	9291000000	5637000000	64.82
free cash flow	8508000000	4846000000	75.57
capital expenditure	-783000000	-791000000	1.01
depreciation and amortization	1186000000	1064000000	11.47
deferred income tax	-401000000	-181000000	-121.55
stock based compensation	195000000	203000000	-3.94
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	-598000000	0	NaN
investments in property plant and equipment	-783000000	-791000000	1.01
net cash used for investing activites	-3845000000	-1069000000	-259.68
debt repayment	-1000000	3600000000	-100.03
common stock issued	0	0	NaN
common stock repurchased	-444000000	-251000000	-76.89
dividends paid	-1953000000	-1986000000	1.66
net cash used provided by financing activities	-2425000000	1216000000	-299.42
net change in cash	3342000000	5675000000	-41.11
cash at end of period	14688000000	11346000000	29.46
cash at beginning of period	11346000000	5671000000	100.07

Overall Score of Quarterly Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 3,342 million in 2024Q3 from 5,675 million in 2024Q2 representing a change of -41.11%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -783 million in 2024Q3 from -791 million in 2024Q2 representing a change of 1.01%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 9,291 million in 2024Q3 from 5,637 million in 2024Q2 representing a change of 64.82%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 8,508 million in 2024Q3 from 4,846 million in 2024Q2 representing a change of 75.57%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 195 million in 2024Q3 from 203 million in 2024Q2 representing a change of -3.94%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Dividends Paid: Dividends Paid increased to -1,953 million in 2024Q3 from -1,986 million in 2024Q2 representing a change of 1.66%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	23.06	23.41	-1.52
net income per share	0.14	5.73	-97.56
operating cash flow per share	4.99	7.54	-33.85
free cash flow per share	3.51	5.81	-39.62
cash per share	2.72	5.21	-47.78
book value per share	14.44	18.19	-20.64
tangible book value per share	-0.6	1.81	-133.32
shareholders equity per share	14.41	18.16	-20.64
interest debt per share	13.89	12.5	11.07
market cap	284230714270.14	280925400000	1.18
enterprise value	313657714270.14	298922400000	4.93
pe ratio	778.71	19.35	3,924.61
price to sales ratio	4.73	4.74	-0.22
pocfratio	21.85	14.71	48.54
pfcf ratio	31.09	19.1	62.75
pb ratio	7.56	6.11	23.82
ptb ratio	7.56	6.11	23.82
ev to sales	5.22	5.04	3.48
enterprise value over ebitda	45.41	14.02	223.81
ev to operating cash flow	24.12	15.65	54.05
ev to free cash flow	34.31	20.33	68.78
earnings yield	0.0	0.05	-97.52
free cash flow yield	0.03	0.05	-38.56
debt to equity	0.93	0.67	39.78
debt to assets	0.33	0.28	16.88
net debt to ebitda	4.26	0.84	404.59
current ratio	1.25	1.47	-15.05
interest coverage	2.58	20.17	-87.22
income quality	35.63	1.31	2,610.67
dividend yield	0.03	0.02	4.94
payout ratio	20.4	0.48	4,123.44
sales general and administrative to revenue	0.14	0.13	3.17
research and ddevelopement to revenue	0.51	0.23	122.24
intangibles to total assets	0.37	0.38	-3.26
capex to operating cash flow	0.3	0.23	29.25
capex to revenue	0.06	0.07	-13.18
capex to depreciation	1.0	1.12	-11.12
stock based compensation to revenue	0.01	0.01	17.57
graham number	6.74	48.41	-86.08
roic	0.01	0.22	-96.37
return on tangible assets	0.01	0.21	-97.48
graham net net	-19.56	-15.75	-24.25
working capital	6474000000	11483000000	-43.62
tangible asset value	-1573000000	4585000000	-134.31
net current asset value	-36872000000	-27380000000	-34.67
invested capital	70170000000	74378000000	-5.66
average receivables	9899500000	9340000000	5.99
average payables	4093000000	4436500000	-7.74
average inventory	6134500000	5932000000	3.41
days sales outstanding	62.84	58.18	8.00
days payables outstanding	88.77	89.39	-0.69
days of inventory on hand	143.91	123.92	16.13
receivables turnover	5.81	6.27	-7.41
payables turnover	4.11	4.08	0.70
inventory turnover	2.54	2.95	-13.89
roe	0.01	0.32	-96.92
capex per share	1.48	1.73	-14.50

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2023-12-31 from 0.32 on 2022-12-31, representing a change of -96.92%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 778.71 on 2023-12-31 from 19.35 on 2022-12-31, representing a change of 3924.61%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.25 on 2023-12-31 from 1.47 on 2022-12-31, representing a change of -15.05%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.93 on 2023-12-31 from 0.67 on 2022-12-31, representing a change of 39.78%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
MRK
calendar year	2024	2024	NaN
revenue per share	6.58	6.38	3.18
net income per share	1.25	2.15	-42.08
operating cash flow per share	3.67	2.22	64.95
free cash flow per share	3.36	1.91	75.70
cash per share	5.76	4.5	28.15
book value per share	17.6	17.22	2.17
tangible book value per share	2.31	2.17	6.44
shareholders equity per share	17.58	17.2	2.19
interest debt per share	15.19	15.03	1.03
market cap	287537343266.2	324098600000	-11.28
enterprise value	311075343266.2	350540600000	-11.26
pe ratio	22.77	14.85	53.30
price to sales ratio	17.26	20.06	-13.95
pocfratio	30.95	57.49	-46.17
pfcf ratio	33.8	66.88	-49.47
pb ratio	6.46	7.44	-13.12
ptb ratio	6.46	7.44	-13.12
ev to sales	18.68	21.7	-13.93
enterprise value over ebitda	55.49	47.5	16.82
ev to operating cash flow	33.48	62.19	-46.16
ev to free cash flow	36.56	72.34	-49.45
earnings yield	0.01	0.02	-34.77
free cash flow yield	0.03	0.01	97.89
debt to equity	0.86	0.87	-1.18
debt to assets	0.32	0.34	-3.30
net debt to ebitda	4.2	3.58	17.19
current ratio	1.36	1.47	-6.95
interest coverage	12.07	20.22	-40.30
income quality	2.94	1.03	184.44
dividend yield	0.01	0.01	10.84
payout ratio	0.62	0.36	69.92
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.35	0.18	97.01
intangibles to total assets	0.33	0.34	-2.76
capex to operating cash flow	0.08	0.14	-39.94
capex to revenue	0.05	0.05	-3.99
capex to depreciation	0.66	0.74	-11.19
stock based compensation to revenue	0.01	0.01	-6.83
graham number	22.2	28.86	-23.07
roic	0.04	0.07	-46.81
return on tangible assets	0.04	0.07	-45.31
graham net net	-18.45	-18.0	-2.49
working capital	10775000000	12145000000	-11.28
tangible asset value	5853000000	5503000000	6.36
net current asset value	-32611000000	-30777000000	-5.96
invested capital	72928000000	73511000000	-0.79
average receivables	11511500000	12107000000	-4.92
average payables	3552500000	3516500000	1.02
average inventory	6356500000	6489500000	-2.05
days sales outstanding	61.49	64.85	-5.18
days payables outstanding	79.1	73.77	7.22
days of inventory on hand	137.74	135.62	1.56
receivables turnover	1.46	1.39	5.47
payables turnover	1.14	1.22	-6.74
inventory turnover	0.65	0.66	-1.54
roe	0.07	0.13	-43.32
capex per share	0.31	0.31	-0.93

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 22.77 on 2024-09-30 Q3 from 14.85 on 2024-06-30 Q2, representing a change of 53.30%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.86 on 2024-09-30 Q3 from 0.87 on 2024-06-30 Q2, representing a change of -1.18%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.36 on 2024-09-30 Q3 from 1.47 on 2024-06-30 Q2, representing a change of -6.95%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 146.39 which is higher than current price 101.85, indicates the company may be undervalued.